梅花生物：前三季度归母净利润为30.25亿元，同比增长51.61%

Core Viewpoint - Meihua Biological reported a decline in revenue for Q3 2025, but a significant increase in net profit compared to the same period last year [1] Financial Performance - In Q3 2025, the company achieved revenue of 5.935 billion yuan, a year-on-year decrease of 1.71% [1] - The net profit attributable to shareholders for Q3 2025 was 1.257 billion yuan, showing a year-on-year increase of 141.06% [1] - For the first three quarters of 2025, the total revenue was 18.215 billion yuan, down 2.49% year-on-year [1] - The net profit attributable to shareholders for the first three quarters was 3.025 billion yuan, reflecting a year-on-year growth of 51.61% [1]